A pilot study of the safety and tolerance of SCH 39166 in patients with schizophrenia.
Labelle
A
A
de Beaurepaire
R
R
Boulay
L J
LJ
Naber
D
D
Jones
B D
BD
Barnes
T R
TR
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D018492:Dopamine Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010865:Pilot Projects; D011618:Psychotic Disorders / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001552:Benzazepines; D018492:Dopamine Antagonists; C058081:ecopipam